197 related articles for article (PubMed ID: 3109815)
1. Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species.
Chin NX; Neu HC
Chemotherapy; 1987; 33(3):183-8. PubMed ID: 3109815
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
Weinstein RA; Nathan C; Delzell D; Kabins SA
Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
[TBL] [Abstract][Full Text] [Related]
3. Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.
Bustamante CI; Drusano GL; Wharton RC; Wade JC
Antimicrob Agents Chemother; 1987 Apr; 31(4):632-4. PubMed ID: 3111357
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa.
Kuti JL; Florea NR; Nightingale CH; Nicolau DP
Pharmacotherapy; 2004 Jan; 24(1):8-15. PubMed ID: 14740783
[TBL] [Abstract][Full Text] [Related]
5. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
Ramadan MA; Tawfik AF; Shibl AM
Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
[TBL] [Abstract][Full Text] [Related]
6. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
Bartmann K; Tarbuc R
Infection; 1982; 10(6):361-70. PubMed ID: 6818153
[TBL] [Abstract][Full Text] [Related]
7. Fleroxacin combined with rifampin.
Zhang YX; Neu HC
Diagn Microbiol Infect Dis; 1991; 14(1):23-7. PubMed ID: 1901534
[TBL] [Abstract][Full Text] [Related]
8. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. III].
Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
Jpn J Antibiot; 1985 Jun; 38(6):1603-18. PubMed ID: 3930806
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Vurma-Rapp U; Kayser FH; Barberis-Maino L
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa: in vitro susceptibility to antimicrobial drugs, single and combined, with and without defibrinated human blood.
Traub WH; Spohr M; Bauer D
Chemotherapy; 1988; 34(4):284-97. PubMed ID: 3145172
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Neu HC; Chin NX
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):644-50. PubMed ID: 2506029
[TBL] [Abstract][Full Text] [Related]
13. The postantibiotic effect of meropenem and imipenem on selected bacteria.
Nadler HL; Pitkin DH; Sheikh W
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
[TBL] [Abstract][Full Text] [Related]
14. The comparison of in the vitro effect of imipenem or meropenem combined with ciprofloxacin or levofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
Erdem I; Kaynar-Tascioglu J; Kaya B; Goktas P
Int J Antimicrob Agents; 2002 Nov; 20(5):384-6. PubMed ID: 12431875
[TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1987). III. Secular changes in susceptibility].
Kosakai N; Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Yoshida H; Ogata M; Tazaki H
Jpn J Antibiot; 1990 Jun; 43(6):968-1136. PubMed ID: 2122041
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Meyer RD; Pasiecznik K
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
[TBL] [Abstract][Full Text] [Related]
17. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.
Watanabe M; Kotera Y; Yosue K; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jan; 34(1):173-5. PubMed ID: 2183709
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.
Giamarellou H; Petrikkos G
Antimicrob Agents Chemother; 1987 Jun; 31(6):959-61. PubMed ID: 3113330
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of imipenem--a review.
Braveny I
Eur J Clin Microbiol; 1984 Oct; 3(5):456-62. PubMed ID: 6389125
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
Bonacorsi S; Fitoussi F; Lhopital S; Bingen E
Antimicrob Agents Chemother; 1999 Feb; 43(2):213-7. PubMed ID: 9925508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
